Brian Weinshenker
Overview
Explore the profile of Brian Weinshenker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
4843
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Correale J, Solomon A, Cohen J, Banwell B, Gracia F, Gyang T, et al.
Lancet Neurol
. 2024 Sep;
23(10):1035-1049.
PMID: 39304243
The differential diagnosis of multiple sclerosis can present specific challenges in patients from Latin America, Africa, the Middle East, eastern Europe, southeast Asia, and the Western Pacific. In these areas,...
2.
Majed M, Valencia Sanchez C, Bennett J, Fryer J, Mulligan M, Redenbaugh V, et al.
Ann Neurol
. 2023 Jun;
94(4):727-735.
PMID: 37314750
Objective: This study was undertaken to investigate factors associated with aquaporin-4 (AQP4)-IgG serostatus change using a large serological database. Methods: This retrospective study utilizes Mayo Clinic Neuroimmunology Laboratory data from...
3.
Yamamura T, Weinshenker B, Yeaman M, De Seze J, Patti F, Lobo P, et al.
Mult Scler Relat Disord
. 2022 Aug;
66:104025.
PMID: 36007339
Background: This analysis evaluated long-term safety findings from the SAkuraSky and SAkuraStar studies with satralizumab in patients with neuromyelitis optica spectrum disorder (NMOSD). Methods: SAkuraSky (satralizumab in combination with baseline...
4.
Tur C, Dubessy A, Otero-Romero S, Amato M, Derfuss T, Di Pauli F, et al.
Mult Scler
. 2022 Feb;
28(9):1424-1456.
PMID: 35196927
Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) has evolved very rapidly and a large number of disease-modifying treatments (DMTs) are now...
5.
Saadeh R, Bryant S, McKeon A, Weinshenker B, Murray D, Pittock S, et al.
Mayo Clin Proc
. 2021 Dec;
97(4):738-751.
PMID: 34893322
Objective: To determine and validate a cerebrospinal fluid (CSF) κ (KCSF) value statistically comparable to detection of CSF-specific oligoclonal bands (OCB) to support the diagnosis of multiple sclerosis (MS). Patients...
6.
Marignier R, Hacohen Y, Cobo-Calvo A, Probstel A, Aktas O, Alexopoulos H, et al.
Lancet Neurol
. 2021 Aug;
20(9):762-772.
PMID: 34418402
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently identified autoimmune disorder that presents in both adults and children as CNS demyelination. Although there are clinical phenotypic overlaps between MOGAD, multiple...
7.
Solomon A, Pettigrew R, Naismith R, Chahin S, Krieger S, Weinshenker B
Mult Scler
. 2020 Mar;
27(2):250-258.
PMID: 32162581
Objective: To assess comprehension and application of the McDonald criteria. Background: Studies suggest that knowledge gaps for specific core elements of the McDonald criteria may contribute to multiple sclerosis (MS)...
8.
Drulovic J, Martinovic V, Dujmovic Basuroski I, Mesaros S, Mader S, Weinshenker B, et al.
Mult Scler Relat Disord
. 2019 Oct;
36:101413.
PMID: 31586803
Background: Neuromyelitis optica spectrum disorder (NMOSD) most commonly, although not exclusively, targets optic nerves and spinal cord. Untreated, early and severe disability is common. We evaluated the long-term outcome in...
9.
Palace J, Lin D, Zeng D, Majed M, Elsone L, Hamid S, et al.
Brain
. 2019 Apr;
142(5):1310-1323.
PMID: 30938427
Pathogenic antibodies targeting the aquaporin-4 water channel on astrocytes are associated with relapsing inflammatory neuromyelitis optica spectrum disorders. The clinical phenotype is characterized by recurrent episodes of optic neuritis, longitudinally...
10.
Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, et al.
Neurology
. 2018 Sep;
91(17):e1642-e1651.
PMID: 30258024
Objective: To define the frequency, duration, and severity of intractable nausea, vomiting, or hiccups in aquaporin-4-immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica spectrum disorder (NMOSD) and propose diagnostic criteria and a severity...